TheStreet Ratings

10 Best Healthcare & Biotech ETFs for 2016 - TheStreet Ratings

Top-Rated ETFs

Top Healthcare/Biotech ETFs as of 9/30/16

Fund NameGet InfoOverall RatingRisk Grade
iShares US Medical Devices ETFIHIAB-
iShares US Healthcare ETFIYHB+B
Vanguard HealthCare Index ETFVHTBB-
ETFis BioShares Biotech ProductsBBPB-C
Health Care Select Sector SPDRXLVB-C+
iShares Global HealthcareIXJC+B
iShares US Healthcare Providers ETFIHFC+B
Fidelity MSCI Health Care Index ETFFHLCC+B
iShares US Pharmaceuticals ETFIHEC+C+
First Trust AMEX BiotechnologyFBTCC

Source: TSC Ratings

Access our ETF Research Center

TheStreet Ratings' model ranks the risk-adjusted returns on all ETFs on a monthly basis.

The 10 healthcare and biotech ETFs (listed above) are ranked highest by TheStreet Ratings' methodology.

Best ETFs for

ETF Investing Center

Healthcare & Biotech ETFs

Johnson & Johnson is undergoing a transformation in its product portfolio. These three ETFs may benefit if investors are excited about third-quarter results.
10/17/16 12:08PM
Why Trump is killing biotech stocks, the Shire-for-Radius rumor makes no sense and Bernie Sanders gets a tweeting lesson.
10/17/16 11:31AM
Driving sector performance are a recent series of mergers and acquisitions, including Horizon Pharma's purchase of Raptor Pharmaceutical Corp. Then there's the political boost...
9/26/16 3:17PM
Stocks in the health care sector are vulnerable to declines following the 2016 presidential election, according to S&P analyst Scott Kessler.
9/22/16 2:33PM
Your retirement portfolio could get a salutary boost from biotech stocks along with ETFs in the sector that have generated large returns in 2016, producing double digit-gains.
8/31/16 10:58AM
Stifel Nicolaus Portfolio Manager Chad Morganlander and MKM Partners chief market technician Jonathan Krinsky discussed the potential breakout for biotech stocks on Monday's CNBC 'Power Lunch'
8/22/16 3:36PM
Two new reports show how the U.S. healthcare system is falling short, despite six years of Obamacare. Simon Constable explains what's happening and what it means for investors.
8/7/16 1:20PM
Concerns that the market is overvalued continue to arise as the S&P 500 has increased by 7.6% during the past two weeks. But there may still be room for growth.
7/14/16 11:56AM
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
7/1/16 7:01AM
When an activist investor such as Carl Icahn takes a position in a stock, other investors rush in and bid up the share price. That's not always a good dea.
6/1/16 10:17AM